Philip R. Dormitzer

机构：Pfizer (United States) · ORCID：0000-0003-0671-6360

发表论文 153 篇 · 总被引 38651 次 · h-index 61

代表论文

• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (2020 · New England Journal of Medicine · 被引 15754)
• Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents (2021 · New England Journal of Medicine · 被引 938)
• BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans (2021 · Nature · 被引 843)
• BNT162b vaccines protect rhesus macaques from SARS-CoV-2 (2021 · Nature · 被引 762)
• Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera (2021 · Nature Medicine · 被引 676)
• Neutralizing Activity of BNT162b2-Elicited Serum (2021 · New England Journal of Medicine · 被引 633)